»áÇ°ÑÐÌÖ»áίÍÐÖÆÔì¸ß·å»áÒé
»áºóÑÐÌÖ»áÁÙ´²ÊµÑéºÏ×÷¸ß·å»áÒé 

ίÍÐÖÆÔì¸ß·å»áÒé
4ÔÂ14ÈÕ(Ò») 

  Sponsored by

In the face of competitive pricing pressure as well as the gain of access to the burgeoning Asian market, there is a growing need of outsourcing biologics manufacturing to Asia CMOs. A recent survey showed that more than 90% of the interviewed biopharma and biotech companies worldwide expressed that they might consider outsourcing biologics manufacturing to a contractor in Asia in order to obtain a price advantage given that quality, IP protection and regulatory requirements are met. The percentage of the biologics manufacturing work conducted in Asia is expected to grow rapidly in the next 10 years as Asiafs manufacturing infrastructures continue to mature.

This summit provides a timely and strategic platform to convene biopharmaceutical manufacturing outsourcing leaders from international and asian biopharma and biotech companies, as well as CMOs from across the entire Asia-Pacific region to discuss the best outsourcing strategies, leverage on the opportunities presented by Asiafs booming biomanfuacturing industry and explore potential business partnerships.

>> Òé³Ì

ÁÙ´²ÊµÑéºÏ×÷¸ß·å»áÒé
4ÔÂ17ÈÕ(ËÄ)

     Sponsored by

Asia-Pacific countries are increasingly becoming the locations of choice for pharma and biotech companies conducting clinical trials. Lower costs, large and diverse patient pools, and quality contract services are some of the major factors that drive the booming clinical research
industry in the region.

In fact, studies have shown that the Asian clinical research organisation markets earned revenues of $1.2 billion in 2006 and this number is projected to reach $2 billion in 2010.

Against this setting, Clinical Partnering Summit will bring together clinical development professionals from international pharma and biotech companies, contract research companies and hospitals to
exploit clinical trial partnering opportunities offered by Asia, as well as to discuss and share case studies, challenges and strategies in approaching clinical trials partnerships.